Details of the Drug Reposition

General Information of This Drug (ID: DMNUDO0)

Drug Name
Voyager-V1   DMNUDO0
Synonyms VSV-IFNBeta-NIS
Drug Type
Oncolytic virus therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hepatocellular carcinoma DIS0J828 2C12.02 Phase 2 [1]
Non-small-cell lung cancer DISI0V1B 2C25 Phase 2 [1]
Melanoma DIS1RRCY 2C30 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04291105) Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. U.S. National Institutes of Health.